Article Text

Download PDFPDF
Long-acting risperidone increases medication costs and does not improve outcomes in unstable schizophrenia

Statistics from Altmetric.com

Footnotes

  • Sources of funding: The Veterans Affairs Cooperative Studies Program. An unrestricted grant and the study drug (long acting risperidone) were provided by Ortho-McNeil Janssen Scientific Affairs, LLC.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.